Beacon Stone Capital decreased its stake in Biopol Chemicals from 3.33% to 2.31%, selling 110,400 shares for ₹1.06 Cr at ₹96.00 apiece.
A specialty chemicals manufacturer engaged in producing silicones, emulsifiers, biochemicals, and polyelectrolytes for diverse industrial applications. Biopol Chemicals operates across multiple chemical segments, serving various end-user industries with formulated chemical solutions and specialty products. The company focuses on manufacturing high-performance biochemical and polymer-based formulations designed for industrial and commercial use across different sectors.
Beacon Stone Capital is a Singapore variable capital company that is an active anchor investor in Indian SME and listed equity offerings.